A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price ...

Key Takeaways The S&P 500 advanced 1.1% on Wednesday, March 5, as the White House announced it would delay tariffs affecting ...

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

Moderna (NASDAQ:MRNA) shares jumped 16% on Wednesday, March 5, following a favorable German court decision that determined ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Moderna, Inc. (NASDAQ:MRNA) shares rose for a second day on Wednesday, adding 15.94 percent to finish at $35.21 apiece as ...

The S&P 500 has soared in recent times, delivering two consecutive years of double-digit gains, and investors -- from ...

For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...

While the details surrounding the new virus are still unfolding, the market's reaction reflects concern over the potential ...

Madison Mills examines the trending headlines Wall Street investors need to know on today's Market Minute. Moderna (MRNA) shares pop after a German court ruled that Pfizer (PFE) and BioNTech (BNTX) ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.